Search

Sanofi SA

Closed

SectorHealthcare

75.88 0.76

Overview

Share price change

24h

Current

Min

75.03

Max

75.8

Key metrics

By Trading Economics

Income

317M

1.9B

Sales

1.1B

12B

P/E

Sector Avg

22.994

68.51

EPS

2.09

Dividend yield

5.53

Profit margin

15.699

Employees

74,846

EBITDA

-1B

1.7B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+24.98% upside

Dividends

By Acuity

Dividend yield

Sector Avg

5.53%

2.29%

Next Earnings

30 paź 2026

Market Stats

By TradingEconomics

Market Cap

-3.8B

89B

Previous open

75.12

Previous close

75.88

News Sentiment

By Acuity

39%

61%

87 / 340 Ranking in Healthcare

Sanofi SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

10 sie 2026, 23:56 UTC

News

Iovance Biotherapeutics reported second-quarter revenue of $99.3 million, a 66% increase, contributing to a rise in shares during after-market hours.

10 sie 2026, 23:52 UTC

Event
News
Social Media

Plug Power shares are higher in after-market trading following strong second-quarter results that exceeded analyst expectations and an improved revenue growth outlook.

10 sie 2026, 23:51 UTC

News

First Horizon Corp shares rise in after-market hours following James Petrillo's appointment as Vice President, De Novo New Build Leader to enhance banking centers.

10 sie 2026, 23:51 UTC

News
Social Media

Riot Platforms reported Q2 revenue of $174.2 million, exceeding expectations. Shares rose sharply in after-hours trading following a major data center lease announcement.

10 sie 2026, 23:51 UTC

News
Social Media

FutureFuel Corp reported second-quarter revenues of $78.7 million, a 120.6% increase year-over-year. Shares are trading higher in after-market hours following the results.

10 sie 2026, 23:51 UTC

Event
News
Social Media

Upwork Inc. shares fell sharply in after-market hours following disappointing second-quarter results and lowered full-year revenue guidance of $730 million to $750 million.

10 sie 2026, 23:46 UTC

News

Fortuna Silver Mines acquires the Bambadji Project for $200 million, boosting growth potential in West Africa. Shares are higher in after-market trading.

10 sie 2026, 23:42 UTC

News

AT&T Inc. filed a $1.1 billion term sheet for floating rate notes due in 2028, contributing to lower shares in after-market trading.

10 sie 2026, 23:41 UTC

News

Kyndryl Holdings plans to acquire Healthcare IT Leaders to enhance its healthcare capabilities. Shares are trading higher in after-market hours following the announcement.

10 sie 2026, 23:41 UTC

News

Analysts adjusted price targets for Insmed Inc. after recent evaluations. Shares are higher in after-market trading, reflecting positive sentiment amid these actions.

10 sie 2026, 23:41 UTC

News

Enphase Energy shares are lower in after-market trading following governance enhancements announced by the board after its 2026 Annual Meeting vote.

10 sie 2026, 23:41 UTC

News

Toast Inc. shares are trading lower in after-market hours following Elena Gomez's sale of 17,076 shares, reducing her ownership by 9%.

10 sie 2026, 23:41 UTC

News

Harrow Inc shares declined in after-market hours following a second-quarter EPS miss of -$0.46, despite revenue of $70.66 million exceeding expectations.

10 sie 2026, 23:41 UTC

News

Hf Foods Group Inc reported strong Q2 results, with revenue of $323.8 million and GAAP net income of $2.6 million, driving shares higher in after-market hours.

10 sie 2026, 23:41 UTC

News

Curtiss-Wright Corp raised its share repurchase program to $160 million, boosting investor sentiment as shares gained during after-market hours.

10 sie 2026, 23:41 UTC

News
Social Media

Hims & Hers Health reported a net loss of $86.3 million in Q2, contributing to a decline in share price during after-market trading.

10 sie 2026, 23:41 UTC

News

Rapid7 shares rise in after-hours trading following second-quarter results that exceeded expectations and positive third-quarter guidance.

10 sie 2026, 23:41 UTC

Event
News

Alcon AG reported second-quarter adjusted EPS of $0.84, surpassing estimates. The company raised its fiscal 2026 EPS guidance, boosting shares in after-market hours.

10 sie 2026, 23:41 UTC

News
Social Media

Entravision Communications shares fell sharply after reporting mixed Q2 results, with earnings of $0.19 and revenues of $227.9 million amid declining broadcast advertising revenue.

10 sie 2026, 23:41 UTC

News

Celsius Holdings Inc. shares are lower in after-market trading following significant leadership changes, including the departure of President Eric Hanson.

10 sie 2026, 23:36 UTC

News

Purple Innovation shares fell after the company reported Q2 2026 earnings of -$0.74, missing estimates, and reduced full-year revenue guidance to $420 million to $440 million.

10 sie 2026, 23:36 UTC

Correlated Moves
News

Pomerantz LLP has filed a class action lawsuit against Zillow Group Inc, contributing to a decline in shares during after-market trading.

10 sie 2026, 23:36 UTC

News

Valero Energy shares are higher in after-market trading, reflecting a five-year average annual return of 36.59%, turning a $100 investment into $468.33.

10 sie 2026, 23:36 UTC

News

Phillips Edison & Co Inc shares are lower in after-market hours following a $400 million stock sale announcement, raising concerns over potential dilution.

10 sie 2026, 23:31 UTC

News

Tactile Systems Technology shares fell in after-market hours following a revenue guidance cut, despite a rise in net income and adjusted EBITDA surpassing expectations.

10 sie 2026, 23:31 UTC

News

L3Harris Technologies completed a successful hot-fire test for the Next Generation Interceptor program, boosting shares in after-market trading.

10 sie 2026, 23:31 UTC

News

Definitive Healthcare reported Q2 adjusted EPS of $0.05, exceeding estimates. The stock rose sharply during after-market hours amid positive guidance and CEO comments.

10 sie 2026, 23:26 UTC

News

Rocket Pharmaceuticals reported Q2 net income of $123.2 million, with EPS of $1.08, significantly exceeding estimates. Shares traded higher in after-market hours.

10 sie 2026, 23:26 UTC

News

RadNet Inc reported record Q2 revenue and adjusted EBITDA. Shares are trading higher in after-market hours, reflecting positive investor sentiment following the earnings report.

10 sie 2026, 23:21 UTC

News
Social Media

BridgeBio Pharma Inc. reported second-quarter revenues of $243.7 million, exceeding expectations. Shares are higher in after-market trading amid positive reception for Attruby.

Peer Comparison

Price change

Sanofi SA Forecast

Price Target

By TipRanks

24.98% upside

12 Months Forecast

Average 94.398 EUR  24.98%

High 106.21 EUR

Low 78 EUR

Based on 9 Wall Street analysts offering 12 month price targets forSanofi SA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

5

Buy

4

Hold

0

Sell

Sentiment

By Acuity

87 / 340 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Sanofi SA

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
help-icon Live chat